Nektar Therapeutics, (NASDAQ: NKTR) – Is Now An Attractive Investment – News Parents
Nektar Therapeutics, (NASDAQ: NKTR) – Is Now An Attractive Investment News Parents
A price target is the projected price level of a financial security stated by an investment analyst or advisor and includes assumptions of future activity.
Source: Investment New Feed